How organizations can gain an edge in the enterprise transformation to unified analytics that's accelerating across pharma.
Tanveer Nasir
Advertisement
Vice president and general manager, product management, at IQVIA, where he leads the development of the Commercial Analytics, Agentic, & GenAI Solutions business globally. With over 20 years of experience in technology, data, and analytics, Nasir has held various leadership roles, including senior director and general manager, senior director of machine learning, and director offering lead.
Articles by Tanveer Nasir
Strategies for biopharma in integrating agentic AI—to achieve incremental gains in efficiency, while delivering meaningful progress in how data insights inform commercial decision-making.
A look at the promise and opportunities from this new and advanced type of AI in transforming commercial planning and execution for life sciences companies.
Meeting demands of the new marketplace.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Wegovy HD Injectable Under Accelerated Approval
2
TrumpRx Selling Medicines at Higher Prices Than Other Countries: Report
3
Pharma M&A Roundup: Novartis to Acquire Pan-Mutant-Selective PI3Kα Inhibitor from Synnovation Therapeutics, Collegium to Acquire Azstarys from Corium Therapeutics
4
What Are the ‘Last Mile Issues’ Impacting Pharma?
5